Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.

Whittier KL, Boese EA, Gibson-Corley KN, Kirby PA, Darbro BW, Qian Q, Ingram WJ, Robertson T, Remke M, Taylor MD, O'Dorisio MS.

Acta Neuropathol Commun. 2013 Oct 10;1(1):66. doi: 10.1186/2051-5960-1-66.

PMID:
24252460
[PubMed - in process]
Free PMC Article
2.

Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth.

Mediavilla-Varela M, Luddy K, Noyes D, Khalil FK, Neuger AM, Soliman H, Antonia SJ.

Cancer Biol Ther. 2013 Sep;14(9):860-8. doi: 10.4161/cbt.25643. Epub 2013 Jul 17.

PMID:
23917542
[PubMed - in process]
Free PMC Article
3.

Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts.

Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Goldring MB, Borea PA, Varani K.

PLoS One. 2013 May 31;8(5):e65561. doi: 10.1371/journal.pone.0065561. Print 2013.

PMID:
23741498
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.

Desmet CJ, Gallenne T, Prieur A, Reyal F, Visser NL, Wittner BS, Smit MA, Geiger TR, Laoukili J, Iskit S, Rodenko B, Zwart W, Evers B, Horlings H, Ajouaou A, Zevenhoven J, van Vliet M, Ramaswamy S, Wessels LF, Peeper DS.

Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5139-44. doi: 10.1073/pnas.1222085110. Epub 2013 Mar 12.

PMID:
23483055
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Chemotherapy and dietary phytochemical agents.

Sak K.

Chemother Res Pract. 2012;2012:282570. doi: 10.1155/2012/282570. Epub 2012 Dec 20.

PMID:
23320169
[PubMed]
Free PMC Article
6.

Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles.

Jayasekara PS, Phan K, Tosh DK, Kumar TS, Moss SM, Zhang G, Barchi JJ Jr, Gao ZG, Jacobson KA.

Purinergic Signal. 2013 Jun;9(2):183-98. doi: 10.1007/s11302-012-9338-z. Epub 2012 Nov 20.

PMID:
23179047
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells.

Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Borea PA, Varani K.

PLoS One. 2012;7(6):e39317. doi: 10.1371/journal.pone.0039317. Epub 2012 Jun 25.

PMID:
22761760
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.

Tosh DK, Phan K, Gao ZG, Gakh AA, Xu F, Deflorian F, Abagyan R, Stevens RC, Jacobson KA, Katritch V.

J Med Chem. 2012 May 10;55(9):4297-308. doi: 10.1021/jm300095s. Epub 2012 Apr 30.

PMID:
22486652
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.

Varani K, Padovan M, Vincenzi F, Targa M, Trotta F, Govoni M, Borea PA.

Arthritis Res Ther. 2011;13(6):R197. doi: 10.1186/ar3527. Epub 2011 Dec 6.

PMID:
22146575
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Putative role of the adenosine A(3) receptor in the antiproliferative action of N (6)-(2-isopentenyl)adenosine.

Blad CC, von Frijtag Drabbe Künzel JK, de Vries H, Mulder-Krieger T, Bar-Yehuda S, Fishman P, Ijzerman AP.

Purinergic Signal. 2011 Dec;7(4):453-62. doi: 10.1007/s11302-011-9244-9. Epub 2011 Jul 1.

PMID:
21720785
[PubMed]
Free PMC Article
11.

GPCR ligand-dendrimer (GLiDe) conjugates: future smart drugs?

Jacobson KA.

Trends Pharmacol Sci. 2010 Dec;31(12):575-9. doi: 10.1016/j.tips.2010.09.002. Epub 2010 Oct 18.

PMID:
20961625
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Structure based prediction of subtype-selectivity for adenosine receptor antagonists.

Katritch V, Kufareva I, Abagyan R.

Neuropharmacology. 2011 Jan;60(1):108-15. doi: 10.1016/j.neuropharm.2010.07.009. Epub 2010 Jul 15.

PMID:
20637786
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.

Katritch V, Jaakola VP, Lane JR, Lin J, Ijzerman AP, Yeager M, Kufareva I, Stevens RC, Abagyan R.

J Med Chem. 2010 Feb 25;53(4):1799-809. doi: 10.1021/jm901647p.

PMID:
20095623
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

Buxton IL, Yokdang N, Matz RM.

Cancer Lett. 2010 May 28;291(2):131-41. doi: 10.1016/j.canlet.2009.09.021. Review.

PMID:
19926395
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk